Get started
666

ZHAOKE OPHTHALMOLOGY LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

6622 chart


Full chart

6622 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪770.06 M‬ HKD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.45 HKD
Net income (FY)
‪−425.47 M‬ HKD
Revenue (FY)
‪20.72 M‬ HKD
Shares float
‪341.93 M‬
Beta (1Y)
0.92

Employees


Employees (FY)
313
Change (1Y)
+20 +6.83%
Revenue / Employee (1Y)
‪8.47 K‬ HKD
Net income / Employee (1Y)
‪−174.03 K‬ HKD

About ZHAOKE OPHTHALMOLOGY LTD


Sector
Health Technology
CEO
Xiao Yi Li
Headquarters
Guangzhou
Website
zkoph.com
Founded
2017
FIGI
BBG010498PX4
Zhaoke Ophthalmology Ltd. operates as holding company, which engages in the provision of ophthalmic pharmaceuticals. It focuses on the research, development, and commercialization of therapies and ophthalmic drugs. The company was founded in January 2017 and is headquartered in Guangzhou, China.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

6622 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6622 is 1.46 HKD — it has decreased by −2.08% in the past 24 hours. Watch ZHAOKE OPHTHALMOLOGY LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange ZHAOKE OPHTHALMOLOGY LTD stocks are traded under the ticker 6622.
6622 stock has fallen by −0.70% compared to the previous week, the month change is a −18.02% fall, over the last year ZHAOKE OPHTHALMOLOGY LTD has showed a −64.04% decrease.
We've gathered analysts' opinions on ZHAOKE OPHTHALMOLOGY LTD future price: according to them, 6622 price has a max estimate of 2.50 HKD and a min estimate of 2.50 HKD. Watch 6622 chart and read a more detailed ZHAOKE OPHTHALMOLOGY LTD stock forecast: see what analysts think of ZHAOKE OPHTHALMOLOGY LTD and suggest that you do with its stocks.
6622 reached its all-time high on Apr 29, 2021 with the price of 15.60 HKD, and its all-time low was 1.28 HKD and was reached on Oct 21, 2024. View more price dynamics on 6622 chart.
See other stocks reaching their highest and lowest prices.
6622 stock is 3.55% volatile and has beta coefficient of 0.92. Track ZHAOKE OPHTHALMOLOGY LTD stock price on the chart and check out the list of the most volatile stocks — is ZHAOKE OPHTHALMOLOGY LTD there?
Yes, you can track ZHAOKE OPHTHALMOLOGY LTD financials in yearly and quarterly reports right on TradingView.
ZHAOKE OPHTHALMOLOGY LTD is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
6622 earnings for the last half-year are −0.15 HKD per share, whereas the estimation was −0.37 HKD, resulting in a 58.82% surprise. The estimated earnings for the next half-year are −0.42 HKD per share. See more details about ZHAOKE OPHTHALMOLOGY LTD earnings.
ZHAOKE OPHTHALMOLOGY LTD revenue for the last half-year amounts to ‪53.47 M‬ HKD, despite the estimated figure of ‪12.52 M‬ HKD. In the next half-year revenue is expected to reach ‪18.94 M‬ HKD.
6622 net income for the last half-year is ‪−82.14 M‬ HKD, while the previous report showed ‪−163.41 M‬ HKD of net income which accounts for 49.73% change. Track more ZHAOKE OPHTHALMOLOGY LTD financial stats to get the full picture.
No, 6622 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 11, 2024, the company has 313.00 employees. See our rating of the largest employees — is ZHAOKE OPHTHALMOLOGY LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZHAOKE OPHTHALMOLOGY LTD EBITDA is ‪−271.33 M‬ HKD, and current EBITDA margin is ‪−2.17 K‬%. See more stats in ZHAOKE OPHTHALMOLOGY LTD financial statements.
Like other stocks, 6622 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZHAOKE OPHTHALMOLOGY LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZHAOKE OPHTHALMOLOGY LTD technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZHAOKE OPHTHALMOLOGY LTD stock shows the sell signal. See more of ZHAOKE OPHTHALMOLOGY LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.